Viewing Study NCT04501250


Ignite Creation Date: 2025-12-24 @ 4:50 PM
Ignite Modification Date: 2025-12-28 @ 1:24 AM
Study NCT ID: NCT04501250
Status: COMPLETED
Last Update Posted: 2020-08-06
First Post: 2020-08-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russia) and Humulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method
Sponsor: Geropharm
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module